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Macroscopic Evaluat ion of Recta l Cancer Resect ion
Specimen: Cl in ica l Significance of the Pathologis t in
Qual i ty Control
By Iris D. Nagtegaal, Cornelis J.H. van de Velde, Erik van der Worp, Ellen Kapiteijn, Phil Quirke,
and J. Han J.M. van Krieken and the Pathology Review Committee for the Cooperative Clinical Investigators of the
Dutch Colorectal Cancer Group
Purpose: Quality assessment and assurance are im-
portant issues in modern health care. For the evaluation
of surgical procedures, there are indirect parameters
such as complication, recurrence, and survival rates.
These parameters are of limited value for the individual
surgeon, and there is an obvious need for direct param-
eters. We have evaluated criteria by which pathologists
can judge the quality or completeness of the resection
specimen in a randomized trial for rectal cancer.
Patients and Methods: The pathology reports of all
patients entered onto a Dutch multicenter randomized
trial were reviewed. All participating pathologists had
been instructed by workshops and videos in order to
obtain standardized pathology work-up. A three-tiered
classification was applied to assess completeness of the
total mesorectal excision (TME). Prognostic value of this
classification was tested using log-rank analysis of
Kaplan-Meier survival curves using the data of all pa-
tients who did not receive any adjuvant treatment.
Results: Included were 180 patients. In 24% (n 
43), the mesorectum was incomplete. Patients in this
group had an increased risk for local and distant recur-
rence, 36.1% v 20.3% recurrence in the group with a
complete mesorectum (P  .02). Follow-up is too short
to observe an effect on survival rates.
Conclusion: A patient’s prognosis is predicted by
applying a classification of macroscopic completeness
on a rectal resection specimen. We conclude that pa-
thologists are able to judge the quality of TME for rectal
cancer. With this direct interdisciplinary assessment
instrument, we establish a new role of the pathologist
in quality control.
J Clin Oncol 20:1729-1734. © 2002 by American
Society of Clinical Oncology.
FOR MANY YEARS, pathology has had an importantrole in the medical audit. There has always been a
strong focus on autopsies, but also in surgical pathology
the interaction between clinician and pathologist has
quality-control aspects (often implicit). In many aspects
of medical care, new quality assessment instruments are
being developed and tested. Treatment processes are
being optimized, standardized, and evaluated to provide
evidence-based treatment.
Because the surgeon is a key factor in prevention of the
development of local recurrence of rectal cancer,1,2 various
studies have been performed to evaluate the effectiveness of
surgical treatment for rectal cancer.3-7 Perioperative mortal-
ity,4,6 rate of complications,6 number of local recurrences,5,6
and 5-year survival3-7 are often used for quality assessment.
The value of these parameters, however, is often limited
because of the large numbers of patients per surgeon and the
long follow-up periods needed for reliable data. Therefore,
these indirect parameters are of limited value for the
individual surgeon. Subsequent changes in practice also
take a long time before they can be evaluated, reducing our
ability to implement therapy improvement rapidly. Direct
evaluation of the result of surgery is potentially much more
informative for a surgeon. Recently, we and others2 showed
that an optimal surgical technique is of utmost importance
in the treatment of rectal cancer, because a decrease in local
recurrence rates from 22%9 to 8%8 can be reached.
Total mesorectal excision (TME) has become the surgical
treatment of choice,2 instead of the conventional surgery
performed in the past, consisting of partial blunt dissection
of the rectum along the presacral fascia cone-wise directed
towards the rectal wall. A package around the tumor
consisting of a mesorectal fat envelope is created by precise
sharp dissection within the true pelvis.1 Quality control of
this procedure can be achieved using the completeness of
this mesorectal envelope as a parameter.10 Both the resec-
tion specimen as a whole and the sliced tumor will provide
useful information about the completeness of excision.
Serious damage to the mesorectal cylinder is an indication
of incomplete excision of the tumor and consequently
increases the risk of local recurrence. We have shown
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previously that careful assessment of the circumferential
margin (CRM) is a strong instrument with which to predict
local recurrence.11-13 However, there are still many local
recurrences that cannot be explained by circumferential
margin involvement. We hypothesize that, in addition to an
assessment of the CRM, routine determination and report-
age of the quality of the mesorectum might improve the
prognostic value of the pathologic work-up and eventually
improve the quality of the surgical technique.
In the Dutch trial of radiotherapy plus TME, standardiza-
tion of treatment for rectal cancer was achieved.8 We
evaluated the quality of the mesorectal excision of the
patients treated in this trial by examining the resection
specimen on arrival at the pathology department. Direct
observations by pathologists are described in the pathology
reports provided. We report that in the majority of cases
pathologists can perform an assessment of the quality of
TME surgery and that the result is clinically relevant.
PATIENTS AND METHODS
Study Population
Patients were selected from a large multicenter trial, the radiotherapy
plus TME trial, in which 1,530 Dutch patients were included from
January 1996 through December 1999. This prospectively randomized
trial evaluated TME surgery with or without preoperative radiotherapy
(5  5 Gy). Patients with a clinically resectable adenocarcinoma of the
rectum were included in this study, and were subsequently randomized
to radiotherapy followed by TME or TME alone. Radiotherapy,
surgical, and pathologic procedures were standardized and quality
controlled.14 Follow-up of all patients was conducted according to the
trial protocol for at least 36 months. Outcome measures included local
and distant recurrences. These were confirmed by radiographic imaging
and histologic diagnosis.
Patient Selection
For the current study, we analyzed the data of the nonirradiated
patients in the trial. The following patient groups were also excluded
from the analysis: no rectal adenocarcinoma (n  10), previous other
malignancy (n  11), no resection (n  3), and distant metastases at
operation (n  28). We analyzed the data of all 180 patients for whom
detailed descriptions of the specimen were present in the pathology
report. The median follow-up of the patients in this selection was 25.8
months.
TME Surgery
All patients underwent surgery according to the principle of TME, as
has been described before.1,9 To guarantee a standard surgical opera-
tion technique within the trial, instructor surgeons supervised the first
five operations by any surgeon.
Pathologic Procedures
Standardized routine pathology examination was performed in the
pathology laboratories of the referring hospitals using the protocol of
Quirke et al.11 Participating pathologists were trained in this technique
by studying videos and newsletters and attending workshops. A
pathology review committee was installed to evaluate the pathologic
work-up. Together with the pathology quality manager,13 they ensured
constant quality of the pathology data and procedures.
On arrival at the laboratory, the completeness of the specimen was
evaluated using the definitions as described below. Pathologists from
the referral hospital recorded pathologic information of the resected
tumor on a standard form for all patients. Photographic documentation
of the resection specimen was required. The resection specimen was
photographed at the moment of arrival at the pathology laboratory,
and after fixation, inking, and slicing, the coronal sections were
subsequently photographed. However, the quality of the images
obtained was not sufficient to judge the completeness of the
mesorectum reliably. Careful examination of the CRM and investi-
gation of tumor invasion of the bowel wall and surrounding tissue
were performed. The largest diameter of the tumor was registered
after fixation of the specimen. The specimens were examined for the
presence of lymph nodes, and all lymph nodes found were processed
for microscopic investigation.
Macroscopic Judgment of the Resection Specimen
The quality of the mesorectum was determined using pathology
reports and scored using three grades:
● Complete: intact mesorectum with only minor irregularities of a
smooth mesorectal surface. No defect is deeper than 5 mm, and
there is no coning toward the distal margin of the specimen. There
is a smooth circumferential resection margin on slicing (Fig 1A
and 1B).
● Nearly complete: moderate bulk to the mesorectum, but irregular-
ity of the mesorectal surface. Moderate coning of the specimen is
allowed. At no site is the muscularis propria visible, with the
exception of the insertion of the levator muscles.
● Incomplete: little bulk to mesorectum with defects down onto
muscularis propria and/or very irregular circumferential resection
margin (Fig 1C and 1D).
Data Collection and Statistics
All case record forms were sent to the central data office at the
surgery department of the Leiden University Medical Center in Leiden.
The data were checked and entered onto a database and analyzed with
the SPSS package (Statistical Product and Service Solutions 9.0 for
Windows; SPSS, Inc, Chicago, IL).
Relations between various parameters were analyzed using Mann-
Whitney and Kruskal-Wallis nonparametric testing procedures. Uni-
variate survival analyses of time to local recurrence, distant metastasis,
or death were performed using the Kaplan-Meier method, with the time
of surgery as the entry date. Differences in observed survival between
groups were tested for statistical significance using log-ranks tests.
Multivariate analysis was performed using the forward stepwise elim-
ination method in the Cox proportional hazards regression model; P 
.05 was considered statistically significant.
RESULTS
Patient Characteristics
From the 180 patients for whom information was avail-
able about the quality of the mesorectum in the reports, 102
specimens (56.6%) were classified as complete, 35 (19.4%)
as nearly complete, and 43 (23.9%) as incomplete mesorec-
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tum (Table 1). The distance of the tumor from the anal verge
is strongly associated with quality of the mesorectum.
Lower tumors (distal border  5 cm from the anal verge)
showed only 39% complete excision, compared with 67%
in the group of tumors located more than 10 cm from the
anal verge. There is also a related difference regarding the
operative technique: abdominoperineal resections showed a
complete mesorectum in 34% compared with 73% in the
group in which a low anterior resection was performed.
There was no relation between age and sex of the patients
and the quality of the resection specimen.
Relation With Circumferential Margin Involvement
Forty-one patients had a positive resection margin, de-
fined as tumor cells within 1 mm of the inked resection
margin. In patients with a positive resection margin, 44% of
the specimens were incomplete, compared with 11% in the
patients with margins greater than 1 cm (P  .001) (Table
2). Both lateral tumor extension and positive lymph nodes
present in the resection margin can cause a positive margin.
In 44% of the tumor, node, metastases (TNM) stage III
patients in whom margin involvement was determined by
the primary tumor, the mesorectum was incomplete. This
is significantly higher than in patients with a negative
margin (24%, P  .05). No such difference was found in
patients in whom the margin was determined by a
positive lymph node: 25% had an incomplete mesorec-
tum (CRM-positive) compared with 23% in patients with
a negative margin (P  .46).
Clinical Implication
We did not observe any difference in prognosis between
the groups with complete and nearly complete mesorectum,
and we combined these groups for further analyses. Overall
recurrence rates were worse in the group with incomplete
mesorectum at 2-year follow-up. In the group with an
incomplete mesorectum, the overall recurrence rate after
2-year follow-up was 35.6% compared with 21.5% in the
group with a nearly complete mesorectum (P  .01) (Fig
2). This could be attributable mainly to the local recur-
rences (15.0% v 8.7%), although this difference was not
significant. No difference was found in survival rates
(76% v 86%, P  .10).
As mentioned before, incomplete resection leads to more
positive margins, but in patients with a positive resection
margin, there was no added value of the quality assessment
of surgery on prognosis (P  .97). However, in patients
with a negative resection margin, the overall recurrence rate
was increased in the group with incomplete mesorectum
(28.6% v 14.9%, P  .03), so determination of the quality
of the mesorectum does have additional value in patients
without CRM involvement (Fig 3). Both local recurrence
(11.4% v 5.5%, P  .09) and distant recurrence (19.2% v
12.2%, P  .11) contributed to this effect. Survival rates
Fig 1. Illustrations of the definitions used to judge resection specimens. (A and B) Complete mesorectum, with (A) no defects, no coning and (B) smooth
circumferential margin. (C and D) Incomplete mesorectum with (C) deep defects and (D) very irregular circumferential margin.
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were different between the groups: 90.5% in the patients
with a complete mesorectum v 76.9% in the patients with an
incomplete mesorectum (P  .05) (Fig 4).
DISCUSSION
Our data show that evaluation of the mesorectum by
pathologists has prognostic implication: recurrence occurs
more often in patients with an incomplete mesorectum. This
is only partly explained by the higher frequency of positive
resection margin in this patient group. Indeed, we also show
that in CRM-negative patients, the determination of the
quality of surgery provides additional prognostic informa-
tion. Quality of surgery and margin involvement are sepa-
rate but related issues.
The assessment of the quality of the resection specimen
(ie, surgical performance) can be helpful in the determina-




(n  102) (%)
Nearly
Complete
(n  35) (%)
Incomplete
(n  43) (%) P
Sex .87
Men 117 58.1 18.8 23.1
Women 63 54.0 20.6 25.4
Age, years .90
Mean 64.2 64.0 64.9 64.1
Range 37-85 38-83 37-84 45-85
Operation type  .001
LAR 102 72.5 12.7 14.7
Hartmann 8 50.0 12.5 37.5
APR 70 34.3 30.0 35.7
Tumor location .007
 5 cm 61 39.3 32.8 27.9
5-10 cm 74 64.9 10.8 24.3
 10 cm 42 66.7 16.7 16.7
Unknown 3
Tumor size, cm .15
Mean 4.8 4.6 5.2 5.0
Median 4.5 4.5 5.0 4.5
Invasion depth .13
T1 9 55.6 33.3 11.1
T2 50 68.0 14.0 18.0
T3 110 53.6 20.0 26.4
T4 11 36.4 27.3 36.4
Nodal status .35
N0 97 59.8 20.6 19.6
N 83 53.0 18.1 28.9
NOTE. Differences were tested with the Kruskal-Wallis test. Data are presented in percentages, except for age (years) and tumor size (cm).
Abbreviations: LAR, low anterior resection; APR, abdominoperineal resection.
Table 2. Relation Between Completeness of the Mesorectum and
Circumferential Margin Involvement
CRM (cm) No. Complete (%)
Nearly
Complete (%) Incomplete (%)
 0.10 41 26.8 29.3 43.9
0.11-0.20 18 50.0 22.2 27.8
0.21-0.50 36 52.8 19.4 27.8
0.51-1.00 31 71.0 16.1 12.9
 1.00 54 75.9 13.0 11.1
NOTE. Significantly more incomplete mesorectums were present in the
group of patients with positive margins (Kruskal-Wallis test, P  .001).
Fig 2. Relation of completeness of mesorectal excision with overall
recurrence rates. Patients with a complete mesorectum show significantly
lower overall recurrence rates than patients with an incomplete mesorectum
(P  .01). Log-rank testing was used.
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tion of the cause of margin involvement, because margin
involvement is not per se a sign of poor surgery, but might
be a reflection of advanced tumor growth. In small tumors
confined to the muscularis propria without lymph node
involvement (TNM stage I), margin involvement is only
possible when the mesorectum is incompletely excised.
In the current series, in only one patient with a TNM
stage I tumor was the margin positive. The mesorectum
in this case was indeed classified as incomplete, demon-
strating that poor surgery can lead to positive margins
even in small tumors.
In advanced tumors, a positive margin can be because of
either the tumor characteristics or incomplete surgery. In the
patients with margins greater than 1 cm, 11% of the mesorec-
tums are incomplete, reflecting poor surgery. It must therefore
be assumed that in patients with positive margins (44% of
which showed incomplete mesorectum), a part of the positive
margin is most likely caused by a poor surgical technique.
Because there are also many cases with complete mesorectum
and margin involvement (27% of the total), we can conclude
that advanced tumor growth is responsible for at least one third
of the positive margins. This implies that CRM has only
limited value as a quality assessment instrument for rectal
cancer surgery, although it remains very relevant for patient
management.
In our analysis, we combined “optimal surgery” cases and
cases with nearly complete mesorectum, because we did not
find statistical differences between these groups. However, we
do not want to give the impression that “coning in” on the
rectal specimen is acceptable, and we want to stress that
optimal surgery (ie, complete mesorectum) remains the goal.
Recently, a few studies concerning the preoperative
imaging of rectal carcinoma have revealed that it is possible
to predict the tumor-free resection margin by magnetic
resonance imaging.15,16 A reliable prediction of a tumor-
free margin will be possible in those cases with complete
mesorectal excision, but not in the group with positive
margins because of insufficient surgery.
We also show that when surgeons use the TME technique,
which is improved surgical technique with regard to local
control, clinically relevant differences exist in quality of
surgery performed. It was not possible to relate these outcomes
to experience of surgeons, because of the low number of
patients with information about the quality of mesorectum per
surgeon. However, factors beyond the surgeon’s influence are
also important in determining the final quality of resection.
With the direct assessment of the quality of the performed
resection by the surgical pathologist, a completely new way
of quality evaluation is established. The relevance of this
evaluation is clear, because the judgment of the TME
resection specimen provides useful information about the
prognosis of patients, especially about the probability of
local and distant recurrence.
Presently, pathologists provide data to predict the course of
disease by diagnosing, classifying, and staging (TNM) the
primary tumor. We show that a role in quality assessment may
be very valuable in the multidisciplinary approach to patients
with rectal cancer. We realize that the direct evaluation of the
quality of surgery needs an altered relationship between sur-
geons and pathologists, on the basis of trust. We believe that
pathologists and surgeons need to see this as a challenge.
Fig 3. Clinical implications of quality assessment in patients with nega-
tive resection margins. Patients with a complete mesorectum show lower
overall recurrence rates than patients with an incomplete mesorectum (P 
.03). Log-rank testing was used.
Fig 4. Clinical implications of quality assessment in patients with nega-
tive resection margins. Patients with a complete mesorectum show higher
survival rates than patients with an incomplete mesorectum (P < .05).
Log-rank testing is used.
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APPENDIX
The appendices listing members of the Pathology Review Committee and the Cooperative Clinical Investigators of the
Dutch Colorectal Cancer Group are available online at www.jco.org.
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